Clinical Trials Directory

Trials / Completed

CompletedNCT02592265

Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden

Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden and Social Participation.

Status
Completed
Phase
Study type
Observational
Enrollment
233 (actual)
Sponsor
Lille Catholic University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to measure economic burden of Multiple Sclerosis (MS) from a new point of view that includes consequences of disability on Quality Of Life (QOL), social participation and capabilities of patients and caregivers. To the investigators' knowledge, there is currently no data including intangible costs related to caregivers and calculating the overall economic cost of Multiple Sclerosis, particularly, in France.

Detailed description

The goal of this study is to evaluate prospectively the economic burden of Multiple Sclerosis (MS) in France by calculating direct costs (medical and non-medical) and indirect costs and by estimating consequences of MS on utility (QALY) of patients and caregivers in a societal perspective.

Conditions

Timeline

Start date
2012-10-01
Primary completion
2015-08-01
Completion
2016-06-01
First posted
2015-10-30
Last updated
2024-09-19

Source: ClinicalTrials.gov record NCT02592265. Inclusion in this directory is not an endorsement.